The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
AABB News is the association's monthly magazine. It is a benefit of AABB membership and offers news and feature stories on critical issues affecting transfusion medicine and biotherapies. Each month's issue comprises feature articles on critical topics in the field, interviews with influential leaders, information on AABB events, member news and much more. Read this month's issue now, or visit the archive of past issues below.
This issue of AABB News focuses on innovation in transfusion medicine and the evolution of technology in the blood and biotherapies community.
This issue of AABB News focuses on global advancements in sickle cell disease treatment and improving patient care in underserved regions.
This issue of AABB News focuses on the rapid growth of the blood and biotherapies field throughout the Middle East.
This issue of AABB News focuses on expanding biotherapies to improve health outcomes and how our community is playing a vital role in this growing area of medicine.
The March 2025 issue of AABB News focuses on how our community is helping to address blood needs throughout the world, particularly in resource-limited settings.
The articles in this issue of AABB News focus on disaster preparedness and reflect our community’s resilience, commitment and willingness to support one another in the face of unexpected events.
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide.
©2022 All Rights Reserved. AABB - Association for the Advancement of Blood & Biotherapies
Web Design and Development by Matrix Group International, Inc.